Key Points Merck is seeking ways to prepare for a significant upcoming patent cliff.The company has just announced another ...

While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...

Our warm weather season is short, and it’s important to enjoy the outdoors. The point isn’t to be sun-scared — just stay ...

Key Points Healthcare is a complex sector, but some dividend payers have proven incredibly reliable over the long ...

In addition to these quarterly earnings, Merck & Co., Inc. (NYSE:MRK) has shown its resilience as a dividend stock. The ...

Merck & Company, Inc. (NYSE:MRK) is one of the high-margin pharma stocks to buy now. Jefferies has raised its price target on ...

Merck KGaA said its Ezmekly therapy for people with a rare genetic disorder has received the conditional marketing approval ...

Biotech deals involving assets developed in China are surging, a Jefferies report shows. | Biotech deals involving assets ...

Five months after taking over the federal agency responsible for the health of all Americans, Robert F. Kennedy Jr. wants to ...

The HHS secretary and four of his advisers earned at least $3.2 million from their work opposing Big Pharma and promoting ...

From J&J to BMS, New Jersey pharmaceutical companies continue to expand and transform through M&A, leadership shifts and ...

Merck & Co. Inc. closed 36.67% below its 52-week high of $128.73, which the company reached on July 26th.